Entera Bio Ltd (NAS:ENTX)
$ 2 -0.03 (-1.48%) Market Cap: 72.65 Mil Enterprise Value: 65.02 Mil PE Ratio: 0 PB Ratio: 8.33 GF Score: 39/100

Q1 2022 Entera Bio Ltd Earnings Call Transcript

May 18, 2022 / 12:00PM GMT
Release Date Price: $2.38 (+4.85%)
Operator

Greetings, and welcome to Entera Bio's First Quarter '22 Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the call over to (inaudible) of Investor Relations. Thank you. You may begin.

Unidentified Company Representative

Good morning, and welcome to the call. Joining me today are Spiros Jamas, our Chief Executive Officer; and Miranda Toledano, Chief Business Officer, Chief Financial Officer and Head of Strategy. A press release announcing Entera's financial and operating results for the first quarter ended March 31, 2022, was issued on May 12, 2022. For those of you who have not received it, it is available on the company's website in the Investors section at www.enterabio.com.

Before we begin our prepared remarks, I would like to remind you that various statements the company makes during this call about future results and operations and financial positions, are -- or interpretations of data from completed and ongoing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot